File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.biopsych.2005.07.007
- Scopus: eid_2-s2.0-32544444840
- PMID: 16169527
- WOS: WOS:000235670800007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Neurological abnormalities in schizophrenic twins
Title | Neurological abnormalities in schizophrenic twins |
---|---|
Authors | |
Keywords | Concordant Discordant Genetic Neurological abnormalities Schizophrenia Twins |
Issue Date | 2006 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/biopsychiat |
Citation | Biological Psychiatry, 2006, v. 59 n. 4, p. 341-348 How to Cite? |
Abstract | Background: Neurological abnormalities (NAs) are well recognized in schizophrenia, though their genetic and environmental determinants, and pathophysiological significance, are poorly understood. Methods: Sixty-three twin pairs, varying in their zygosity and concordance for schizophrenia, and 73 unaffected control twin pairs were examined for total, primary and integrative NAs using the Neurological Evaluation Scale. Results: NAs were increased in probands with schizophrenia compared to nonschizophrenic co-twins and to healthy control twins but there were no significant differences between patients from the concordant and discordant pairs. NAs in the nonpsychotic co-twins from discordant pairs were increased compared to control twins. There were no significant differences in NAs between the nonschizophrenic co-twins from monozygotic (MZ) and dizygotic (DZ) discordant pairs, but the within pair correlations were greater in the MZ compared to DZ pairs. NAs were modified in all groups by pre-morbid schizotypal traits, and in patients by anti-psychotic medication. Conclusions: NAs in schizophrenia are determined in part by genetic risk for the illness but the presence of premorbid schizotypal traits, and anti-psychotic medication confer additional risk for NAs. © 2006 Society of Biological Psychiatry. |
Persistent Identifier | http://hdl.handle.net/10722/141861 |
ISSN | 2023 Impact Factor: 9.6 2023 SCImago Journal Rankings: 3.786 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Picchioni, MM | en_HK |
dc.contributor.author | Toulopoulou, T | en_HK |
dc.contributor.author | Landau, S | en_HK |
dc.contributor.author | Davies, N | en_HK |
dc.contributor.author | Ribchester, T | en_HK |
dc.contributor.author | Murray, RM | en_HK |
dc.date.accessioned | 2011-09-27T03:03:27Z | - |
dc.date.available | 2011-09-27T03:03:27Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | Biological Psychiatry, 2006, v. 59 n. 4, p. 341-348 | en_HK |
dc.identifier.issn | 0006-3223 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/141861 | - |
dc.description.abstract | Background: Neurological abnormalities (NAs) are well recognized in schizophrenia, though their genetic and environmental determinants, and pathophysiological significance, are poorly understood. Methods: Sixty-three twin pairs, varying in their zygosity and concordance for schizophrenia, and 73 unaffected control twin pairs were examined for total, primary and integrative NAs using the Neurological Evaluation Scale. Results: NAs were increased in probands with schizophrenia compared to nonschizophrenic co-twins and to healthy control twins but there were no significant differences between patients from the concordant and discordant pairs. NAs in the nonpsychotic co-twins from discordant pairs were increased compared to control twins. There were no significant differences in NAs between the nonschizophrenic co-twins from monozygotic (MZ) and dizygotic (DZ) discordant pairs, but the within pair correlations were greater in the MZ compared to DZ pairs. NAs were modified in all groups by pre-morbid schizotypal traits, and in patients by anti-psychotic medication. Conclusions: NAs in schizophrenia are determined in part by genetic risk for the illness but the presence of premorbid schizotypal traits, and anti-psychotic medication confer additional risk for NAs. © 2006 Society of Biological Psychiatry. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/biopsychiat | en_HK |
dc.relation.ispartof | Biological Psychiatry | en_HK |
dc.subject | Concordant | en_HK |
dc.subject | Discordant | en_HK |
dc.subject | Genetic | en_HK |
dc.subject | Neurological abnormalities | en_HK |
dc.subject | Schizophrenia | en_HK |
dc.subject | Twins | en_HK |
dc.title | Neurological abnormalities in schizophrenic twins | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Toulopoulou, T:timothea@hku.hk | en_HK |
dc.identifier.authority | Toulopoulou, T=rp01542 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.biopsych.2005.07.007 | en_HK |
dc.identifier.pmid | 16169527 | - |
dc.identifier.scopus | eid_2-s2.0-32544444840 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-32544444840&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 59 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 341 | en_HK |
dc.identifier.epage | 348 | en_HK |
dc.identifier.isi | WOS:000235670800007 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Picchioni, MM=6507443795 | en_HK |
dc.identifier.scopusauthorid | Toulopoulou, T=8855468700 | en_HK |
dc.identifier.scopusauthorid | Landau, S=7101776972 | en_HK |
dc.identifier.scopusauthorid | Davies, N=7202610654 | en_HK |
dc.identifier.scopusauthorid | Ribchester, T=6506172219 | en_HK |
dc.identifier.scopusauthorid | Murray, RM=35406239400 | en_HK |
dc.identifier.issnl | 0006-3223 | - |